Vijaya Diagnostic Centre Ltd

Vijaya Diagnost. Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Vijaya Diagnostic Centre Ltd

₹ 690 -0.14%
26 Apr 9:37 a.m.
vijayadiagnostic.com BSE: 543350 NSE : VIJAYA
About

Vijaya Diagnostics Centre limited is a leading diagnostic medicare services provider in Southern India and offers comprehensive services that include nuclear medicine, radiology, laboratory, health check-ups and medical services. The company provides its services across 13 cities through its 81 diagnostic centers and 11 reference laboratories.[1]

Key Points

Largest Diagnostic Chain in Southern India [1]
Vijaya Diagnostic Center Ltd. (VDCL) is the largest integrated diagnostic chain in South India, by revenue and also one of the fastest-growing diagnostic chains by revenue for FY23.

Website BSE NSE
  • Market Cap ₹ 7,066 Cr.
  • Current Price ₹ 690
  • High / Low ₹ 719 / 360
  • Stock P/E 62.8
  • Book Value ₹ 58.3
  • Dividend Yield 0.14 %
  • ROCE 18.2 %
  • ROE 16.3 %
  • Face Value ₹ 1.00
Edit ratios

Pros

Cons

  • Stock is trading at 11.9 times its book value
  • Promoter holding has decreased over last quarter: -0.81%

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Healthcare Industry: Healthcare

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023
97 110 119 110 108 114 102 118 111 118 119 136 129
52 56 64 59 61 67 63 70 67 70 71 80 78
Operating Profit 45 54 55 50 47 47 39 48 44 48 47 56 51
OPM % 47% 49% 46% 46% 44% 41% 38% 41% 39% 41% 40% 41% 40%
3 3 3 3 3 3 3 3 4 5 6 7 3
Interest 4 3 4 4 4 4 5 5 6 6 6 6 6
Depreciation 12 12 12 12 13 15 14 16 20 11 12 14 14
Profit before tax 32 42 43 37 33 31 23 31 22 36 35 44 34
Tax % 25% 26% 25% 26% 25% 24% 26% 25% 25% 24% 26% 25% 25%
24 31 32 27 25 23 17 23 16 27 26 33 25
EPS in Rs 53.25 6.81 3.17 2.68 2.45 2.30 1.69 2.25 1.58 2.64 2.55 3.21 2.47
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 TTM
238 279 329 367 451 450 502
160 187 196 204 251 271 299
Operating Profit 78 92 133 163 200 179 203
OPM % 33% 33% 40% 44% 44% 40% 40%
5 9 12 11 13 15 21
Interest 4 4 15 15 16 21 24
Depreciation 23 26 48 50 52 61 52
Profit before tax 56 70 82 110 144 111 148
Tax % 36% 31% 25% 24% 25% 25%
35 49 61 83 108 83 111
EPS in Rs 78.17 108.02 135.13 18.28 10.60 8.15 10.87
Dividend Payout % 0% 0% 0% 0% 9% 12%
Compounded Sales Growth
10 Years: %
5 Years: 14%
3 Years: 11%
TTM: 13%
Compounded Profit Growth
10 Years: %
5 Years: 18%
3 Years: 13%
TTM: 41%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: 79%
Return on Equity
10 Years: %
5 Years: 23%
3 Years: 22%
Last Year: 16%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Sep 2023
Equity Capital 5 5 5 5 10 10 10
Reserves 162 211 273 356 460 535 586
26 36 156 137 183 248 253
31 40 41 36 58 57 72
Total Liabilities 224 292 475 533 711 850 922
102 137 264 261 364 517 563
CWIP 3 3 10 9 34 28 15
Investments 77 73 58 32 59 144 200
42 80 143 231 254 161 143
Total Assets 224 292 475 533 711 850 922

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
62 77 109 128 155 163
-100 -91 -34 -129 -127 -108
-7 8 -28 -48 -25 -41
Net Cash Flow -44 -7 46 -49 4 13

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Debtor Days 14 14 9 7 8 7
Inventory Days 24 19 23 16 22 12
Days Payable 152 175 163 133 108 172
Cash Conversion Cycle -115 -142 -130 -110 -79 -153
Working Capital Days -22 -28 -30 -11 -22 -25
ROCE % 33% 27% 27% 28% 18%

Shareholding Pattern

Numbers in percentages

4 Recently
Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
54.78% 54.78% 54.78% 55.04% 55.01% 55.01% 55.01% 54.98% 54.90% 54.87% 54.06%
23.36% 26.37% 28.12% 27.99% 23.89% 24.96% 25.28% 20.27% 20.68% 19.95% 20.09%
15.89% 14.97% 13.08% 12.81% 15.77% 14.22% 13.90% 19.02% 18.64% 19.82% 20.80%
5.97% 3.88% 4.02% 4.16% 5.33% 5.79% 5.81% 5.73% 5.78% 5.36% 5.03%
No. of Shareholders 1,20,57082,13979,02177,22976,98579,05976,53273,85072,79566,20466,724

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Credit ratings

Concalls